Janus Henderson Group PLC Agios Pharmaceuticals, Inc. Put Options Transaction History
Janus Henderson Group PLC
- $187 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AGIO
# of Institutions
230Shares Held
55.4MCall Options Held
301KPut Options Held
254K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$332 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$325 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$285 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.88MShares$227 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.78MShares$163 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $3.21B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...